Brain+ A/S
CSE:BRAINP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Brain+ A/S
Cash from Financing Activities
Brain+ A/S
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Brain+ A/S
CSE:BRAINP
|
Cash from Financing Activities
kr10.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NNIT A/S
CSE:NNIT
|
Cash from Financing Activities
-kr24m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
18%
|
|
|
M
|
Monsenso A/S
CSE:MONSO
|
Cash from Financing Activities
kr1.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Brain+ A/S
Glance View
Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.
See Also
What is Brain+ A/S's Cash from Financing Activities?
Cash from Financing Activities
10.4m
DKK
Based on the financial report for Dec 31, 2024, Brain+ A/S's Cash from Financing Activities amounts to 10.4m DKK.
What is Brain+ A/S's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-25%
Over the last year, the Cash from Financing Activities growth was -25%. The average annual Cash from Financing Activities growth rates for Brain+ A/S have been -25% over the past three years .
